Zoznam zdrojov INUSpherese®
Sources related to the INUSpherese® TKM-58:
Straube, R.; Müller, g.; Voit-Bak, K.; Tselmin, S.; Julius, U.;
Schatz, U.; Rietzsch, H.; Reichmann, H.; Chrousos, G.P.;
Schürmann, A.; Jark, L.; Ziemssen, T.; Siepmann,
T. & Bornstein, S.R. (2019).
Metabolic and non-metabolic peripheral neuropathy: Is there a place for therapeutic apheresis? Hormone and Metabolic Research,
51 (12), 779-784
Straube, R.; Voit-Bak, K.; Gor, A.; Steinmeier, T.; Chrousos, G.P.; Boehm, B.O.; Birkenfeld, A.L.; Barbir, M.; Balantsev, W. & Bornstein, S.R. (2019).
Lipid profiles in Lyme borreliosis: A potential role for apheresis?
Hormones and Metabolic Research, 51 (05), 326-329.
Bornstein, S.R.; Voit-Bak, K.; Morawietz, H.; Bornstein, A.B.;
Balantsev, W.; Julius, U.; Rodionov, R.N.; Biener, A.M.; Wang, J.; Schulte, K.M.; Krebs, P.; Vollmer, G. & Straube, R. (2020).
Is there a role for environmental and metabolic factors predisposing to severe COVID-19? Hormones and Metabolic Research, 52 (07), 540-546.
Bornstein, S.R.; Voit-Bak, K.; Rosenthal, P.; Tselmin, S.; Julius, U.; Schatz, U.; Boehm, B.O.; Thuret, S.; Kempermann, G.;
Reichmann, H.; Chrousos, G.P.; Licino, J.; Wong, M.-L.; Schal-ly, A.V. (Nobel prize winner) & Straube, S.R. (2020).
Extracorporeal apheresis therapy for Alzheimer disease-targeting lipids, stress, and inflammation. Molecular Psychiatry, 25, 275-282.
Bornstein, S.R.; Voit-Bak, K.; Donate, T.; Rodionov, R.N.; Gainetdinov, R.R.; Tselmin, S.; Kanczowski, W.; Müller, G.M.; Achleitner, M.; Wangm, J.; Licino, J.; Bauer, M.; Young, A.H.; Thuret, S.; Bechmann, N. & Straube, R. (2022).
Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis? Molecular Psychiatry, 27, 34-37.
Yin, X.; Takov, K.; Straube, R.; Voit-Bak, K.; Graessler, J.; Julius, U.; Tselmin, S.; Rodionov, R.; Barbir, M.; Walls, M.; Theofilators, K.; Mayr, M. & Bornstein, S.R. (2022).
Precision medicine approach for cardiometabolic risk factors in therapeutic apheresis. Hormones and Metabolic Research, 54 (04), 238-249.
Scholkmann, F. & Tsenkova, R. (2022).
changes in water properties in human tissue after double filtration plasmapheresis. Molecules, 27 (12), 3947. Scholkmann, F. & Gatti, A.M. (2022).
Particles in the eluate from double filtration plasmapheresis___A case study using field emission scanning electron microscopy/energy-dispersive X-ray spectroscopy (FE-SEM/EDX). Compounds, 2 (4), 367-377.
General sources and references: Nadler SB, Hidalgo JU, Block T: Prediction of blood volume in normal human adults. Surgery 1962;
5:224-232.
Cholesterol Treatment Trialists Collaboration (CTT).2015. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomized trials. Lancet 385 Dittrich-Riediger, J.; Schatz, U.; Hohenstein, B. and Julius, U. 2015 Adverse events lipoprotel apheresls and immunoadsorption at the Apheresis Center at the University Hospital Dresden.
Atheroscler. Suppl, 1 8; 45-52. doi: 10.1016/j.atherosclerosissup. 2015.02.007 Caforio AL, Pankuweit sS Arbustini E et al.
Current state of knowledge on etiology, diagnosis, management, and therapy of myocarditis; a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, Eur Heart J 2013; 34:2636-48; 2648a-2648d.
Clifford DB, De Luca A, Simpson DM et al.
Natalizumabassociated progressive multifocal leukoencephalopathy in patients with multiple sclerosis; lessons from 28 cases. Lancet Neuro 2010; 4
Gold R. Dianosis and therapy of multiple sclerosis
In: Diener & Weimar eds, Guidelines for diagnostics and therapies in neurology of the German Society of Neurology, Stuttgart, New York: Thieme, September 2012. URL: https:// www.dgn.org/leitlinien/2333-II-31-2012-diagnose-und-therrapie-dermultiplens-klerose (accessed on August 30, 2017).
Hohenstein B., Passauer J.; Ziemssen T. and Julius U.
Immunoadsorption with regenerating systems in neurological disorders - A single center experience Atheroscler Suppl 2015; 119-123.
Dogan Onugoren MD, Golombeck K, Bien C et al.
Immunoadsorption therapy in autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 2016; 3 (2);e 207 DOI 10.1212/NXI.0000000000000207
Cortese I, Chaudhry V, So Y et al. Evidence-based guideline update:
plasmapheresis in neurologic disorders:
report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology 2011; 76; 294-300.
Sommer c et al. (2018)
Therapy of acute and chronic immune-mediated neuropathies and neuritis, S2e guideline, In: German Society of Neurology (ed.) Guidelines for diagnostics and therapy in neurology.
Berlit P, et al.,
Neurological manifestations in COVID-19, S2k guideline, 2022, In: German Society of Neurology (ed.), Guidelines for diagnostics and therapy in neurology. Online: www.dgn.org/leitlinien
Islam MS, Azim F, Saju H, Zargaran A, Shirzad M, Kamal M, Fatema K, Rehman S, Azad MAM, Ebrahimi-Barough S. J chem Neuroanat. 2021 Sep;
Pesticides and Parkinson's disease: Current and future perspective.
Ascherio A, Schwarzschild MA. Lancet Neurol. 2016 Nov;
The epidemiology of Parkinson's disease: risk factors and prevention
Alvarado-Esquivel C, Méndez-Hernández EM, Salas-Pacheco JM, Ruano-Calderón LÁ, Hernández-Tinoco J, Arias-Carrión O, Sánchez-Anguiano LF, Castellanos-Juárez FX, Sandoval-Carrillo AA, Liesenfeld O, Ramos-Nevárez A. BMJ Open. 2017 Feb
toxoplasma gondii, exposure and Parkinson's disease: a case of control study
Fallahi S, Rostami A, Birjandi M, Zebardast N, Kheirandish F, Spotin A. Acta Trop. 2017.
Parkinson's disease and Toxoplasma gondii infection: Sero-molecular assess the possible link among patients.
Senejani AG, Maghsoudiou J, El-Zohiry D, Gaur G, Wawrzeniak K, Caravaglia C, Khatri VA, MacDonald A, Sapi E. J Alzheimers Dis. 2022.
Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer's Disease Brain Tissues
Haahr R, Tetens MM, Dessau RB, Krogfelt KA, Bodilsen J, Andersen NS, Moller JK, Roed C, Christiansen CB, Ellermann-Eriksen S, Bangsborg JM, Hansen K, Benfield TL, Andersen CO, Obel N, Lebech AM, Omland LH. Clin Infect Dis. 2020 Sep.
Risk of Neurological Disorders in Patients With European Lyme Neuroborreliosis: A Nationwide, Population-Based Cohort Study
Wormser GP, Marques A, Pavia CS, Schwartz I, Feder HM, Pachner AR. Clin Infect Dis. 2022 Aug
Lack of Convincing Evidence That Borrelia burgdorferi Infection Causes Either Alzheimer's Disease or Lewy Body Dementia
MacDonald AG. Med hypotheses. 2006;
Spirochetal cyst forms in neurodegenerative disorders, hiding in plain sight
Parthasarathy G, Pattison MB, Midkiff CC. J Neuroinflammation. 2023 Jan
The FGF/FGFR system in the microglial neuroinflammation with Borrelia burgdorferi: likely intersectionality with other neurological conditions
Seward RJ, Drouin EE, Steere AC, Costello CE. Moi Cell Proteomics, 2011 Mar;
Peptides presented by HLA-DR molecules in sysnovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis
Steere AC, Dwyer E, Winchester R. N Engl J Med. 1990 Jul.
Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles
Weyand CM, Jendro M, Goronzy JJ. Autoimmunity. 1991;
SolubleHLA-DR molecules in patients with HLA class II versus class I associated disorders
Flegr J. Parasite Vectors. 2021 Sep 28;
Toxoplasmosis is a risk factor for acquiring SARS-CoV-2 infection and a
Gustaw K, Beltowska K, Dlugosz E. Ann Agric Environ Med. 2005;
Co-existence of toxoplasmosis and neuroborreliosis - a case report
Shutikova AL, Leonova GN, Popov AF, Shchelkanov MY. Clinic Lab Diagnosis 2021.
Clinical and diagnostic manifestations of tickborne mixed infection in combination with COVID-19 Nov.
Szewczyk-Dabrowska A, Budziar W, Harhala M, Baniecki K, Pikies A, Jedruchniewicz N, Kazmierczak Z, Gembara K, Klimek T, Witkiewicz W, Nahorecki A, Barczyk K, Klak M, Grata-Borkowska U, Dabrowska K. Sci Rep. 2022 Sep 24
Correlation between COVID-19 severity and previous exposure of patients to Borrelia spp